MENLO PARK, Calif.–(BUSINESS WIRE)– #compassionatecare–MedaSystems, a SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs, today announced the release of MedaSystems Version 3.3, one of the company’s most significant platform updates to date.The release introduces new capabilities designed to help pharmaceutical and biotechnology organizations manage increasingly complex patient access programs with greater efficiency, consistency and control. Version 3.3 expand